Literature DB >> 19288456

Detection of C1236T, G2677T/A, and C3435T polymorphism of MDR1 by amplification refractory mutation system PCR.

Bing Chen1, Jie Fang, Weixia Zhang, Zhao Jin, Zichen Yu, Weimin Cai.   

Abstract

C1236T, G2677T/A, and C3435T polymorphism of the multidrug resistance (MDR1) gene have substantial impact on expression or activity of P-glycoprotein (P-gp). We developed new methods based on amplification refractory mutation system (ARMS) to detect these polymorphisms. Tetra-primers amplification in a single tube was established to detect C1236T and C3435T polymorphism. For G2677T/A polymorphism, a two-step allele-specific amplification method was used. MDR1 genotypes of 177 Chinese subjects were determined by the methods we established. The methods we established were verified with gene sequencing. Gene frequencies of 1236C and 1236T were 37.8 and 62.2%, respectively; gene frequencies of 2677G, 2677T and 2677A were 44.1, 38.4 and 17.5%, respectively; the gene frequencies of 3435C and 3435T were 65.0 and 35.0%, respectively. The results were similar with other studies on Oriental subjects. The methods we established are simple, accurate, and economical, and can provide reliable approaches for determining MDR1 polymorphism. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19288456      PMCID: PMC6648974          DOI: 10.1002/jcla.20299

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  23 in total

Review 1.  P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugs.

Authors:  M F Fromm
Journal:  Int J Clin Pharmacol Ther       Date:  2000-02       Impact factor: 1.366

2.  Expression of a multidrug-resistance gene in human tumors and tissues.

Authors:  A T Fojo; K Ueda; D J Slamon; D G Poplack; M M Gottesman; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

3.  Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites.

Authors:  C Cordon-Cardo; J P O'Brien; D Casals; L Rittman-Grauer; J L Biedler; M R Melamed; J R Bertino
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

4.  Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues.

Authors:  F Thiebaut; T Tsuruo; H Hamada; M M Gottesman; I Pastan; M C Willingham
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

5.  Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects.

Authors:  I Cascorbi; T Gerloff; A Johne; C Meisel; S Hoffmeyer; M Schwab; E Schaeffeler; M Eichelbaum; U Brinkmann; I Roots
Journal:  Clin Pharmacol Ther       Date:  2001-03       Impact factor: 6.875

Review 6.  Meta-analysis: a method for synthesizing research.

Authors:  R B D'Agostino; M Weintraub
Journal:  Clin Pharmacol Ther       Date:  1995-12       Impact factor: 6.875

7.  Identification of functionally variant MDR1 alleles among European Americans and African Americans.

Authors:  R B Kim; B F Leake; E F Choo; G K Dresser; S V Kubba; U I Schwarz; A Taylor; H G Xie; J McKinsey; S Zhou; L B Lan; J D Schuetz; E G Schuetz; G R Wilkinson
Journal:  Clin Pharmacol Ther       Date:  2001-08       Impact factor: 6.875

8.  Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene.

Authors:  Deanna L Kroetz; Christiane Pauli-Magnus; Laura M Hodges; Conrad C Huang; Michiko Kawamoto; Susan J Johns; Doug Stryke; Thomas E Ferrin; Joseph DeYoung; Travis Taylor; Elaine J Carlson; Ira Herskowitz; Kathleen M Giacomini; Andrew G Clark
Journal:  Pharmacogenetics       Date:  2003-08

Review 9.  Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance.

Authors:  Catia Marzolini; Erik Paus; Thierry Buclin; Richard B Kim
Journal:  Clin Pharmacol Ther       Date:  2004-01       Impact factor: 6.875

10.  Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo.

Authors:  S Hoffmeyer; O Burk; O von Richter; H P Arnold; J Brockmöller; A Johne; I Cascorbi; T Gerloff; I Roots; M Eichelbaum; U Brinkmann
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

View more
  5 in total

Review 1.  Personalized medicine: is it a pharmacogenetic mirage?

Authors:  Rashmi R Shah; Devron R Shah
Journal:  Br J Clin Pharmacol       Date:  2012-10       Impact factor: 4.335

2.  Post-mortem ABCB1 genotyping reveals an elevated toxicity for female digoxin users.

Authors:  Anu M Neuvonen; Jukka U Palo; Antti Sajantila
Journal:  Int J Legal Med       Date:  2011-02-11       Impact factor: 2.686

3.  Population pharmacokinetic study of cyclosporine in Chinese renal transplant recipients.

Authors:  Bing Chen; WeiXia Zhang; ZhiDong Gu; Juan Li; YuXin Zhang; WeiMin Cai
Journal:  Eur J Clin Pharmacol       Date:  2010-12-16       Impact factor: 2.953

4.  The pharmacokinetics of tacrolimus in peripheral blood mononuclear cells and limited sampling strategy for estimation of exposure in renal transplant recipients.

Authors:  Xi-Han Wang; Kun Shao; Hui-Min An; Xiao-Hui Zhai; Pei-Jun Zhou; Bing Chen
Journal:  Eur J Clin Pharmacol       Date:  2022-05-10       Impact factor: 3.064

Review 5.  Pharmacokinetics, Pharmacodynamics and Pharmacogenetics of Tacrolimus in Kidney Transplantation.

Authors:  Meng Yu; Mouze Liu; Wei Zhang; Yingzi Ming
Journal:  Curr Drug Metab       Date:  2018       Impact factor: 3.731

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.